Cargando…

Association of Serum GFAP with Functional and Neurocognitive Outcome in Sporadic Small Vessel Disease

Cerebrospinal fluid (CSF) and serum biomarkers are critical for clinical decision making in neurological diseases. In cerebral small vessel disease (CSVD), white matter hyperintensities (WMH) are an important neuroimaging biomarker, but more blood-based biomarkers capturing different aspects of CSVD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huss, André, Abdelhak, Ahmed, Mayer, Benjamin, Tumani, Hayrettin, Müller, Hans-Peter, Althaus, Katharina, Kassubek, Jan, Otto, Markus, Ludolph, Albert C., Yilmazer-Hanke, Deniz, Neugebauer, Hermann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405121/ https://www.ncbi.nlm.nih.gov/pubmed/36009416 http://dx.doi.org/10.3390/biomedicines10081869

Ejemplares similares

Serum GFAP as a biomarker for disease severity in multiple sclerosis
por: Abdelhak, A., et al.
Publicado: (2018)

Optical coherence tomography-based assessment of retinal vascular pathology in cerebral small vessel disease
por: Abdelhak, A., et al.
Publicado: (2020)

Author Correction: Serum GFAP as a biomarker for disease severity in multiple sclerosis
por: Abdelhak, A., et al.
Publicado: (2019)

Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies
por: Huss, André, et al.
Publicado: (2020)

A Score Based on NfL and Glial Markers May Differentiate Between Relapsing–Remitting and Progressive MS Course
por: Huss, André, et al.
Publicado: (2020)

Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?
por: Abdelhak, Ahmed, et al.
Publicado: (2015)

Development of an ultrasensitive microfluidic assay for the analysis of Glial fibrillary acidic protein (GFAP) in blood
por: Fazeli, Badrieh, et al.
Publicado: (2023)

Histological correlates of postmortem ultra-high-resolution single-section MRI in cortical cerebral microinfarcts
por: Yilmazer-Hanke, Deniz, et al.
Publicado: (2020)

Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?
por: Abdelhak, Ahmed, et al.
Publicado: (2019)

Correction to: MR‑imaging pattern is not a predictor of occult atrial fibrillation in patients with cryptogenic stroke
por: Vollmuth, Christoph, et al.
Publicado: (2020)

CSF oligoclonal IgG bands are not associated with ALS progression and prognosis
por: Klose, Veronika, et al.
Publicado: (2023)

Clinical and neuroimaging disparity between Chinese and German patients with cerebral small vessel disease: a comparative study
por: Shu, Junlong, et al.
Publicado: (2019)

Andexanet Alfa for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage: Observational Cohort Study
por: Rauch, Sebastian, et al.
Publicado: (2022)

Communicating Hydrocephalus Following Eosinophilic Meningitis Is Pathogenic for Chronic Viliuisk Encephalomyelitis in Northeastern Siberia
por: Storch, Alexander, et al.
Publicado: (2014)

Endothelial damage, vascular bagging and remodeling of the microvascular bed in human microangiopathy with deep white matter lesions
por: Forsberg, Karin M. E., et al.
Publicado: (2018)

Primary Progressive Multiple Sclerosis: Putting Together the Puzzle
por: Abdelhak, Ahmed, et al.
Publicado: (2017)

Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases
por: Abu-Rumeileh, Samir, et al.
Publicado: (2020)

Sporadic inclusion body myositis: no specific cardiac involvement in cardiac magnetic resonance tomography
por: Rosenbohm, Angela, et al.
Publicado: (2020)

Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis
por: Robinson, Tilman, et al.
Publicado: (2020)

The Chemokine CXCL13 Is a Prognostic Marker in Clinically Isolated Syndrome (CIS)
por: Brettschneider, Johannes, et al.
Publicado: (2010)

MRI as a first-line imaging modality in acute ischemic stroke: a sustainable concept
por: Althaus, Katharina, et al.
Publicado: (2021)

Soluble Beta-Amyloid Precursor Protein Is Related to Disease Progression in Amyotrophic Lateral Sclerosis
por: Steinacker, Petra, et al.
Publicado: (2011)

IgG Antibodies against Measles, Rubella, and Varicella Zoster Virus Predict Conversion to Multiple Sclerosis in Clinically Isolated Syndrome
por: Brettschneider, Johannes, et al.
Publicado: (2009)

MR-imaging pattern is not a predictor of occult atrial fibrillation in patients with cryptogenic stroke
por: Vollmuth, C., et al.
Publicado: (2019)

Two histological methods for recognition and study of cortical microinfarcts in thick sections
por: Braak, Heiko, et al.
Publicado: (2018)

Diagnostic biomarkers in tear fluid: from sampling to preanalytical processing
por: Bachhuber, Franziska, et al.
Publicado: (2021)

CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort
por: Senel, Makbule, et al.
Publicado: (2019)

CSF profile in primary progressive multiple sclerosis: Re-exploring the basics
por: Abdelhak, Ahmed, et al.
Publicado: (2017)

Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriers
por: Dorst, Johannes, et al.
Publicado: (2023)

Glial fibrillary acidic protein in cerebrospinal fluid of patients with spinal muscular atrophy
por: Freigang, Maren, et al.
Publicado: (2022)

Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study
por: Abdelhak, Ahmed, et al.
Publicado: (2020)

Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer’s disease with multi-modal PET and plasma GFAP
por: Chiotis, Konstantinos, et al.
Publicado: (2023)

Summary of cerebrospinal fluid routine parameters in neurodegenerative diseases
por: Jesse, Sarah, et al.
Publicado: (2010)

Thrombolysis in central retinal artery occlusion: a retrospective observational study
por: Raber, Florian Philipp, et al.
Publicado: (2022)

Cerebral infarctions following an increase in corticosteroids: an atypical case of reversible cerebral vasoconstriction syndrome
por: Erhart, Deborah Katharina, et al.
Publicado: (2022)

RCVS: by clinicians for clinicians—a narrative review
por: Erhart, Deborah Katharina, et al.
Publicado: (2022)

Varicella zoster virus-induced neurological disease after COVID-19 vaccination: a retrospective monocentric study
por: Abu-Rumeileh, Samir, et al.
Publicado: (2021)

Bevacizumab is associated with cerebral microstructural alterations: a DTI study in high-grade glioma
por: Kassubek, Rebecca, et al.
Publicado: (2023)

GFAP at 50
por: Messing, Albee, et al.
Publicado: (2020)

Neurochemical Biomarkers in patients with COVID-19
por: Tumani, Hayrettin
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_19sfkcsu9irco0v0c85gea62l1